UNIVERSITY OF THE SCIENCES
LIVE

Serial Number

77813531

Owner

Saint Joseph's University

Attorney

Christopher D. Olszyk, Jr.

First Use Date

Jul 1, 1998

Filing Date

Aug 26, 2009

Add to watchlist:

No watchlists yet
View on USPTO

UNIVERSITY OF THE SCIENCES Trademark

Serial Number: 77813531 • Registration: 4175968

UNIVERSITY OF THE SCIENCES is a trademark filed by Saint Joseph's University on August 26, 2009. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Saint Joseph's University (32 trademarks)

Philadelphia, PA 19131

Entity Type: 03

University of the Sciences in Philadelphia (17 trademarks)

600 South 43rd Street
Philadelphia, PA 19104

Entity Type: 99

Trademark Details

Filing Date

August 26, 2009

Registration Date

July 17, 2012

First Use Anywhere

July 1, 1998

First Use in Commerce

July 1, 1998

Published for Opposition

September 6, 2011

Goods & Services

Educational services, namely, providing courses of instruction at the undergraduate, graduate, and post-graduate levels; providing educational research programs for all aspects of pharmaceutical study; providing continuing education conferences, seminars and workshops in the fields of pharmaceutical study, health care, and health sciences; conducting educational conferences and seminars in the fields of the study of pharmacy and the pharmaceutical and health care industries; publication of newsletters, news briefs, and monographs for pharmacists and health care professionals [ ; entertainment services in the nature of presentation of a variety of intercollegiate sporting events, namely, cross-country, cheerleading, rifle, basketball, baseball, golf, tennis, softball, and volleyball ]

[ Providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, research about patient reimbursement for pharmaceuticals and financing the research of others in the field of pharmacoeconomics; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, financing the research of others ]

[ Business consulting services for the pharmaceutical and health care industries, namely, pharmaceutical care management programs in the nature of cost management and drug utilization review for pharmaceutical benefit plans for private and public agencies, organizations, institutions, and individuals; Business research services, namely, providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy utilization and costs reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly, namely, drug utilization review research for the pharmaceutical and health care industries ]

[ Technical consulting services in the nature of pharmaceutical technology consulting for pharmaceutical care management programs provided to private and public agencies, organizations, institutions, and individuals for the pharmaceutical and health care industries; Research consulting services in the nature of pharmaceutical research services for pharmaceutical care management programs for private and public agencies, organizations, institutions, and individuals in the pharmaceutical and health care industries; providing and facilitating pharmacoeconomics research projects and research teams for improving drug therapy selection, utilization, costs, and reimbursements through applied pharmacoeconomics for the pharmaceutical and health care industries, namely, pharmaceutical research services; and providing and facilitating geriatrics-focused research programs dedicated to assessing health care of the elderly by outcomes assessment and drug use and utilization for the pharmaceutical and health care industries, namely, research in the field of pharmaceuticals ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 2, 2023 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 2, 2023 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Feb 2, 2023 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Feb 2, 2023 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 31, 2023 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 27, 2022 ASGN
TEAS SECTION 8 & 9 RECEIVED
Jul 15, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 17, 2021 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 24, 2018 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 24, 2018 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 24, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 12, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 17, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2012 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 12, 2012 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jun 11, 2012 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 4, 2012 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 31, 2012 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 24, 2012 AITU
USE AMENDMENT FILED
May 1, 2012 IUAF
TEAS STATEMENT OF USE RECEIVED
May 1, 2012 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 1, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2011 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 29, 2011 PREV
ASSIGNED TO LIE
Jul 28, 2011 ALIE
ASSIGNED TO LIE
Jul 21, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 18, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jan 18, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jan 18, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2010 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2009 NWOS
NEW APPLICATION ENTERED
Sep 1, 2009 NWAP